Herold M - Search Results

1

Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD 20 antibody rituximab.

Herold M, Schulze A, Härtwig K, Anger G. Herold M, et al. Ann Hematol. 2000 Jun;79(6):332-5. doi: 10.1007/s002779900141. Ann Hematol. 2000. PMID: 10901614

2

Bendamustine, vincristine and prednisone (BOP) versus cyclophosphamide, vincristine and prednisone (COP) in advanced indolent non-Hodgkin's lymphoma and mantle cell lymphoma: results of a randomised phase III trial (OSHO# 19).

Herold M, Schulze A, Niederwieser D, Franke A, Fricke HJ, Richter P, Freund M, Ismer B, Dachselt K, Boewer C, Schirmer V, Weniger J, Pasold R, Winkelmann C, Klinkenstein C, Schulze M, Arzberger H, Bremer K, Hahnfeld S, Schwarzer A, Müller C, Müller C; East German Study Group Hematology and Oncology (OSHO). Herold M, et al. J Cancer Res Clin Oncol. 2006 Feb;132(2):105-12. doi: 10.1007/s00432-005-0023-2. Epub 2005 Aug 9. J Cancer Res Clin Oncol. 2006. PMID: 16088404 Clinical Trial.

3

Reduced combined radiotherapy and chemotherapy for Hodgkin's disease--risk-adapted treatment approach.

Herold M, Anger G, Keinert K, Höche D, Kästner R, Wutke K. Herold M, et al. Recent Results Cancer Res. 1989;117:163-8. doi: 10.1007/978-3-642-83781-4_16. Recent Results Cancer Res. 1989. PMID: 2481327 No abstract available.

4

Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab.

Herold M, Dölken G, Fiedler F, Franke A, Freund M, Helbig W, Pasold R. Herold M, et al. Ann Hematol. 2003 Feb;82(2):77-9. doi: 10.1007/s00277-002-0581-1. Epub 2003 Feb 5. Ann Hematol. 2003. PMID: 12601483 Clinical Trial. No abstract available.

5

Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.

Eichhorst BF, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R, Hallek M; German CLL Study Group (GCLLSG). Eichhorst BF, et al. Blood. 2011 Feb 10;117(6):1817-21. doi: 10.1182/blood-2010-04-282228. Epub 2010 Dec 7. Blood. 2011. PMID: 21139079 Free article.

6

Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO).

Kahl C, Krahl R, Becker C, Al-Ali HK, Sayer HG, Schulze A, Herold M, Hänel M, Scholl S, Hochhaus A, Uharek L, Maschmeyer G, Haehling D, Junghanß C, Peter N, Kämpfe D, Kettner E, Heinicke T, Fischer T, Kreibich U, Wolf HH, Niederwieser D. Kahl C, et al. Among authors: herold m. J Cancer Res Clin Oncol. 2016 Jan;142(1):305-15. doi: 10.1007/s00432-015-2045-8. Epub 2015 Sep 25. J Cancer Res Clin Oncol. 2016. PMID: 26407768

7

[Experiences in the induction of remission and in maintenance therapy in acute myeloblastic leukemia in adults with the RAMPO scheme].

Höche D, Herold M, Fink R, Anger G. Höche D, et al. Among authors: herold m. Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(2):237-43. Folia Haematol Int Mag Klin Morphol Blutforsch. 1981. PMID: 6168533 German. No abstract available.

8

Long-term treatment with rituximab is feasible in selected patients with B-CLL: response-adjusted low-dose maintenance treatment with rituximab in patients with relapsed B-CLL, who achieved a partial or minimal response to prior rituximab therapy.

Srock S, Schriever F, Neubauer A, Herold M, Huhn D. Srock S, et al. Among authors: herold m. Leuk Lymphoma. 2007 May;48(5):905-11. doi: 10.1080/10428190701225874. Leuk Lymphoma. 2007. PMID: 17487734

9

Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia.

Schulz H, Klein SK, Rehwald U, Reiser M, Hinke A, Knauf WU, Aulitzky WE, Hensel M, Herold M, Huhn D, Hallek M, Diehl V, Engert A; German CLL Study Group. Schulz H, et al. Among authors: herold m. Blood. 2002 Nov 1;100(9):3115-20. doi: 10.1182/blood-2002-03-0972. Blood. 2002. PMID: 12384407 Free article. Clinical Trial.

10

[Preliminary results of cyclically alternating chemotherapy (CVPP/DBVCy) in advanced Hodgkin's disease].

Herold M, Anger G, Höche D, Kästner R. Herold M, et al. Med Klin (Munich). 1987 May 8;82(10):345-9. Med Klin (Munich). 1987. PMID: 2439886 Clinical Trial. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

836 results

Search Page

Filters